SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-030426
Filing Date
2018-12-07
Accepted
2018-12-07 17:42:45
Documents
2
Period of Report
2018-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3764
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4294
  Complete submission text file 0000899243-18-030426.txt   9524
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Issuer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02142
Business Address
Slaoui Moncef (Reporting) CIK: 0001712369 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38753 | Film No.: 181224426